Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00440739
Status:
COMPLETED
Last Update Posted:
2009-02-05
First Post:
2006-02-02
Brief Title:
Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy TURP
Sponsor:
Mahidol University
Organization:
Mahidol University
Study Overview
Official Title:
Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy A Factorial Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether etoricoxib flavoxate both are effective in the treatment postoperative pain after TURP
The research hypothesis
There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo
The research hypothesis
There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo
Detailed Description:
Postoperative pain is still a significant problem for surgical patients Conventional use of narcotics for postoperative pain relief is not without serious side effects such as respiratory depression and sedationThere are other alternatives for postoperative analgesia as NSAIDs especially COX2-inhibitors For some specific operation such as TURP which Foleys catheter needed to be retained for a few daysurinary anti spasmodics may help the patients to be more comfortable
Comparisons There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo
Comparisons There is a difference in postoperative morphine consumption in the first 24 hours after transurethral prostatectomy between patients who received etoricoxib or flavoxate or both and placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None